Dr. Gregg Stone and Dr. C. Michael Gibson Discuss: Transcatheter Edge-to-edge Repair of Functional Mitral Regurgitation in Heart Failure: Final Five-year Results From the COAPT Trial March 5, 2023 Disclosures: TBD
Dr. Joo-Yong Hahn and Dr. C. Michael Gibson Discuss: RENOVATE-COMPLEX-PCI: Intravascular Imaging-guided Versus Angiography-guided Procedural Optimization in Complex Percutaneous Coronary Intervention March 5, 2023 Disclosures: TBD
Dr. Enoch Akowuah and Dr. C. Michael Gibson Discuss: Minimally Invasive Versus Conventional Sternotomy For Mitral Valve Repair Surgery: An Expertise Based Multicentre Randomised Controlled Trial (UK Mini Mitral) March 5, 2023 Disclosures: TBD
Dr. Annapoorna Subhash Kini and Dr. C. Michael Gibson Discuss: Effect of Evolocumab on Coronary Plaque Characteristics in Stable Coronary Artery Disease: A Multimodality Imaging Study (the Yellow III Study) March 4, 2023 Disclosures: TBD
Dr. Divaka Perera and Dr. C. Michael Gibson Discuss: Effect of Myocardial Viability, Percutaneous Coronary Intervention and Functional Recovery on Clinical Outcomes in the REVIVED-BCIS2 Randomized Trial March 4, 2023 Disclosures: TBD
Dr. Tomas Neilan, Dr. Marielle Scherrer-Crosbie, and Dr. C. Michael Gibson Discuss: Statins TO Prevent the Cardiotoxicity From Anthracyclines: The STOP-CA Trial March 4, 2023 Disclosures: TBD
Dr. Steven Nissen and Dr. C. Michael Gibson Discuss: Bempedoic Acid And Cardiovascular Outcomes In Statin Intolerant Patients At High Cardiovascular Risk March 4, 2023 Disclosures: TBD
Dr. Rasha Al-Lamee and Dr. C. Michael Gibson Discuss: AHA 2022 ACCess Points Daily Wrap-Up – November 7, 2022 November 7, 2022 Disclosures: TBD
Dr. Marc Bonaca and Dr. C. Michael Gibson Discuss: Aortic Disease Guidelines November 7, 2022 Disclosures: TBD
Dr. David Kandzari and Dr. C. Michael Gibson Discuss: SPYRAL HTN-ON – Effect of Radiofrequency Renal Denervation on Blood Pressure in the Presence of Antihypertensive Drugs: 6-Month Primary Results from the SPYRAL HTN-ON Med Expansion Randomized Trial November 7, 2022 Disclosures: TBD
